M
Melodi
Innovative soft tissue device for breast reconstruction, eluting antibiotics and fully absorbable, reducing complications and re-operations
About Melodi
Melodi Health is a pioneering company in the field of reconstructive surgery, specifically focusing on breast reconstruction for women who have undergone mastectomies. The company operates in the healthcare and medical device market, targeting both patients and surgeons. Its core product, the Melodi Matrix, is a development-stage soft tissue device designed to elute antibiotics directly into the tissue and fully absorb into the body. This innovative product aims to reduce complications and the need for re-operations, which are common issues in breast reconstruction surgeries. The Melodi Matrix features a macroporous structure that permits tissue ingrowth and is pliable to allow for tissue expansion, making it the first of its kind in the market. The company generates revenue through the sale of its medical devices, primarily targeting hospitals and surgical centers involved in breast reconstruction procedures. Currently, Melodi Health is conducting clinical trials to further validate the efficacy and safety of the Melodi Matrix.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2021
- Headquarters
- Minneapolis, United States
- Employees
- 7
- Open positions
- None listed
- Dealroom signal
- 71.7/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, medical implants, Surgery, Women's Health, Femtech, Woman Founder, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b, b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | Aug 2024 | $11M | $43M | Southeast Minnesota Capital Fund · Three Bridges · Engage Venture Partners · HM Venture Partners | ↗ |
| SEEDOther financing | Mar 2023 | $0 | — | Beta | ↗ |
Growth signals
Latest recorded traffic for Melodi is 1.1K monthly website visits, down 15.4% over the last three months. Melodi's team grew 16.7% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Beta
Series A4 investors entered at this stage
Engage Venture Partners
Southeast Minnesota Capital Fund
Three Bridges- HPHM Venture Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Melodi on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Melodi’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







